21-06-2017 15:00
Is EU investment moving research, innovation and business forward?
Altiero Spinelli, room 3E-2, European Parliament, Brussels
On 21.06.17 the CONT Committee held a hearing on “Is EU investment moving research, innovation and business forward? Mid-term (cost-effectiveness) assessment of Horizon 2020". The objective is to highlight achievements, identify weaknesses and propose improvements with the view to enhancing the cost-effectiveness of EU budget investments.
With a budget of almost EUR 80 billion for the period 2014-2020, Horizon 2020 is EU's most powerful public investment tool for research, innovation and technology.
The vast scale and scope of the financing include 26 managing and implementing bodies, 28 Member States, countries outside the European Union and hundreds of thousands of potential beneficiaries of different sizes and from different areas. The ultimate success of EU budget investments via Horizon 2020 depends on the effective and efficient implementation of available funding while focusing on results.
This public hearing aimed at delivering input to a mid-term assessment of Horizon 2020's cost-effectiveness by discussing with representatives of all EU institutions involved, as well as with stakeholders and beneficiaries the challenges ahead.
The vast scale and scope of the financing include 26 managing and implementing bodies, 28 Member States, countries outside the European Union and hundreds of thousands of potential beneficiaries of different sizes and from different areas. The ultimate success of EU budget investments via Horizon 2020 depends on the effective and efficient implementation of available funding while focusing on results.
This public hearing aimed at delivering input to a mid-term assessment of Horizon 2020's cost-effectiveness by discussing with representatives of all EU institutions involved, as well as with stakeholders and beneficiaries the challenges ahead.